CXC motif chemokine receptor 4 (CXCR4) is an attractive target for cancer diagnosis and
treatment, as it is overexpressed in many solid and hematologic malignancies. This study …

In recent years, molecular imaging addressing the CXC motif chemokine receptor 4
(CXCR4) has increasingly been used in various clinical settings. Here, we aimed to assess …

Background The chemokine receptor CXCR4 is frequently overexpressed and associated
with adverse prognosis in most hematopoietic malignancies and solid cancers. Recently …

Abstract Chemokine (CXC motif) receptor 4 (CXCR4) is a key factor for tumor growth and
metastasis in several types of human cancer including multiple myeloma (MM). Proof-of …

CXCR 4 is a G‐protein‐coupled receptor that mediates recruitment of blood cells toward its
ligand SDF‐1. In cancer, high CXCR 4 expression is frequently associated with tumor …

Background CXC motif chemokine receptor 4 (CXCR4) is overexpressed in various solid
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …

68Ga-pentixafor PET/CT imaging allows noninvasive assessment of CXC chemokine
receptor type 4 (CXCR4) expression in various malignancies, but its use in rare lung cancer …

We report the case of a 62-year-old woman with a history of ST-elevation myocardial
infarction who underwent 68 Ga-Pentixafor PET/CT for characterization of postinfarct …

Objectives: 68Ga-Pentixafor positron emission tomography (PET) imaging targets CXCR4
expression which is overexpressed in multiple myeloma (MM). In this study, we evaluated …

Background We aimed to evaluate the interobserver agreement rates in patients scanned
with CXC motif chemokine receptor 4 (CXCR4)–directed PET/CT, including the rate of …